Ignite Creation Date:
2025-12-24 @ 11:31 PM
Ignite Modification Date:
2025-12-29 @ 12:29 AM
Study NCT ID:
NCT04156256
Status:
UNKNOWN
Last Update Posted:
2019-11-12
First Post:
2019-11-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CD123-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies
Sponsor:
iCell Gene Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-03-01
Start Date Type:
ACTUAL
Primary Completion Date:
2020-09-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2020-09-30
Completion Date Type:
ESTIMATED
First Submit Date:
2019-11-06
First Submit QC Date:
None
Study First Post Date:
2019-11-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-08
Last Update Post Date:
2019-11-12
Last Update Post Date Type:
ACTUAL